Clinical Trials Directory

Trials / Completed

CompletedNCT00449826

Risk Stratification of Non ST Elevation ACS With Computed Tomographic Angiography (REACT)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
107 (actual)
Sponsor
Ottawa Heart Institute Research Corporation · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this project is to examine the effectiveness of computed tomographic angiography (CTA) in patients with non-ST elevation acute coronary syndrome (NSTE-ACS). People who are hospitalized with this situation often require an angiogram to assess the heart and its arteries. Recent advancements in technology have enabled CTA to clearly define coronary artery anatomy with great accuracy and to guide treatment strategies in select patient populations. We are investigating that CTA may be used, as an alternative to conventional angiograms, for the risk stratification of patients with high risk NSTE-ACS. Patients eligible for the study will be high risk NSTE-ACS and awaiting an angiogram. Enrolled patients will undergo CTA prior to the angiogram. With each CTA the patient will be injected with a small dose of an X-ray dye and will be asked to lie still on the "scanning bed" for a period of 5-10 minutes.

Conditions

Interventions

TypeNameDescription
PROCEDUREComputed Tomographic AngiographyCT scan

Timeline

Start date
2006-09-01
Primary completion
2008-12-01
Completion
2010-12-01
First posted
2007-03-21
Last updated
2012-01-26

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00449826. Inclusion in this directory is not an endorsement.